Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study

BACKGROUND: Comorbid anxiety symptoms,in patients with a primary anxiety disorder or a mood disorder, leads to poor patient outcomes and burdens the healthcare system. This pilot study evaluated the feasibility of extended-release quetiapine fumarate (quetiapine XR) for the treatment of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Chih, Chen, Chih-Ken, Wang, Liang-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514148/
https://www.ncbi.nlm.nih.gov/pubmed/23020711
http://dx.doi.org/10.1186/1471-244X-12-162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514148/
https://www.ncbi.nlm.nih.gov/pubmed/23020711
http://dx.doi.org/10.1186/1471-244X-12-162

Ejemplares similares